Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Wilmcote Discussions Regarding Arysta LifeScience Acquisition End

18th Jun 2018 16:16

LONDON (Alliance News) - Wilmcote Holdings PLC on Monday said it is no longer in talks with Platform Speciality Products Corp regarding a potential purchase of Arysta LifeScience.

Arysta LifeScience is an agricultural solutions segment of New York-listed chemicals firm Platform Speciality Products.

Wilmcote - which was initially founded to "acquire and subsequently develop target businesses in the chemicals sector" - said it has incurred material third party expenses in connection with this acquisition opportunity.

"We note Arysta LifeScience's announcement today that it is in exclusive discussions with another party," said Wilmcote Chief Executive Adrian Whitfield. "Arysta LifeScience offers an attractive acquisition opportunity for Wilmcote and we will monitor developments with continued interest."

Shares in Wilmcote were suspended last Thursday after it confirmed it was in discussions to acquire an agricultural chemicals business. Shares in Wilmcote were last trading at 119.00 pence each.


Related Shares:

WCH.L
FTSE 100 Latest
Value8,809.74
Change53.53